• Publications
  • Influence
Pre‐ICH warfarin use, not antiplatelets, increased case fatality in spontaneous ICH patients
Anticoagulant and antiplatelets for prevention of ischaemic stroke and cardiovascular diseases may increase the risk of intracerebral hemorrhage (ICH). This study aimed to investigate the influenceExpand
  • 14
  • 1
The Role of the Occipital Artery in the Diagnosis of Intracranial Dural Arteriovenous Fistula Using Duplex Sonography
BACKGROUND AND PURPOSE: The occipital artery is usually a main feeding artery of an intracranial dural arteriovenous fistula. The aim of this study was to establish the role of the OA in theExpand
  • 7
  • PDF
Effects of dl-3-n-butylphthalide on serum VEGF and bFGF levels in acute cerebral infarction.
  • S-C Tang, C-J Luo, +4 authors P. Xue
  • Medicine
  • European review for medical and pharmacological…
  • 1 October 2017
OBJECTIVE To observe the curative effect of dl-3-n-Butylphthalide (NBP) on patients with acute cerebral infarction (ACI) and its effects on levels of serum vascular endothelial growth factor (VEGF)Expand
  • 10
Abstract P2-11-09: A phase 2 randomized trial of the IDO pathway inhibitor indoximod in combination with taxane based chemotherapy for metastatic breast cancer: Preliminary data
Background: Indoleamine 2,3 dioxygenase (IDO) is a tryptophan-catabolizing enzyme that plays a key role in the normal regulation of peripheral immune tolerance. Tumors also employ this mechanism toExpand
  • 6
  • PDF
Cervical oesophagostomy in patients with severe dysphagia following radiotherapy for nasopharyngeal carcinoma
Objective: This study aimed to investigate the validity and feasibility of cervical oesophagostomy as a treatment for patients with severe dysphagia after radiotherapy for nasopharyngeal carcinoma.Expand
  • 4
  • PDF
Abstract P6-17-04: A phase II, open-label, multi-center study of ANG1005, a novel brain-penetrant taxane derivative, in breast cancer patients with recurrent CNS metastases
Background: Treatment options for brain metastases are limited to local therapies due to the inability of most anti-cancer agents to cross the blood brain barrier (BBB). ANG1005 is a novel taxaneExpand
  • 2
Abstract P1-12-01: A phase II, open-label, multi-center study of ANG1005, a novel brain-penetrant peptide-drug conjugate, in breast cancer patients with recurrent CNS metastases
Background: The incidence of CNS metastatic disease in breast cancer patients (pts) seems to have increased in recent years with the improvement of systemic therapy. However, treatment options forExpand